Pharmacogenomics Education in Medical and Pharmacy Schools: Conclusions of a Global Survey
2019 · Pharmacogenomics · 87 citations
https://doi.org/10.2217/pgs-2019-0009
A
Adrián LLerena
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
303
Papers
8.7K
Citations
50
h-index
172
i10-index
Adrián LLerena is an academic researcher from Instituto de Salud Carlos III. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Schizophrenia research and treatment & Drug Transport and Resistance Mechanisms. The author has an h-index of 50, co-authored 258 publications.
ORCID: 0000-0002-5663-7081Papers by this author
works<i>CYP2D6</i>polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits
2007 · Pharmacogenomics · 70 citations
https://doi.org/10.2217/14622416.8.11.1597
VEGF-related polymorphisms identified by GWAS and risk for major depression
2017 · Translational Psychiatry · 50 citations
https://doi.org/10.1038/tp.2017.36
Farmacogenética de reacciones adversas a fármacos antiepilépticos
2015 · Neurología · 43 citations
https://doi.org/10.1016/j.nrl.2015.03.005
Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes
2016 · The Pharmacogenomics Journal · 36 citations
https://doi.org/10.1038/tpj.2016.44
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (<i>5‐HTTLPR‐S</i>) and the <i>CYP2C9*3</i> allele
2007 · Fundamental and Clinical Pharmacology · 33 citations
https://doi.org/10.1111/j.1472-8206.2007.00501.x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat